Market Overview:
The global pediatric vaccines market is expected to exhibit a CAGR of 8.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Pediatric vaccines or immunizations refer to medical supplies that create immunity in infants, children and adolescents. They are utilized for the prevention, treatment and management of diseases and are commonly available in multivalent and monovalent variants. These vaccines are commonly used in pediatric oncology, cardiology, critical care, and pulmonology departments. Pediatric vaccines assist in protecting children from various serious illnesses, such as polio, measles, brain swelling, paralysis, diarrhea and hepatitis. These vaccines are safe, effective, promote a healthier life and protect against infectious or noninfectious diseases.
Pediatric Vaccines Market Trends:
The increasing number of births and the rising prevalence of various pediatric diseases represents the key factor primarily driving market growth. Additionally, the increasing need to promote public health and the widespread adoption of pediatric vaccines as a cost-effective means of advancing global welfare is also propelling the market growth. In line with this, the development of efficacious and safe vaccination that eliminates and decreases dangerous diseases that spread from child to child is favoring the market growth. Furthermore, various product innovations, such as the introduction of new pediatric vaccines that aid in the treatment of adolescents and children with relapsing forms of multiple sclerosis (RMS), are providing a considerable boost to the market growth. Additionally, the increasing demand for conjugate vaccines that consist of antigens and have the ability to elicit immunological memory and reduce asymptomatic carriage of the bacteria is positively impacting the market growth. Apart from this, growing awareness regarding early disease diagnosis and prevention, extensive research and development (R&D) activities and implementation of various government initiatives to promote accurate and timely administration of pediatric vaccination are anticipated to drive the market further toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pediatric vaccines market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, technology and application.
Breakup by Type:
Breakup by Technology:
- Conjugate
- Live Attenuated
- Inactivated
- Subunit
- Toxoid
- Others
Breakup by Application:
- Infectious Disease
- Cancer
- Allergy
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bio-Med Private Limited, Daiichi Sankyo Company Limited, GSK plc, Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Panacea Biotec Limited, Pfizer Inc., Sanofi S.A. and Sinovac Biotech Ltd.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Type, Technology, Application, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, Bio-Med Private Limited, Daiichi Sankyo Company Limited, GSK plc, Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Panacea Biotec Limited, Pfizer Inc., Sanofi S.A. and Sinovac Biotech Ltd. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global pediatric vaccines market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global pediatric vaccines market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global pediatric vaccines market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pediatric Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Multivalent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Monovalent
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Conjugate
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Live Attenuated
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Inactivated
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Subunit
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Toxoid
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Infectious Disease
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Allergy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bio-Med Private Limited
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Daiichi Sankyo Company Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 GSK plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Indian Immunologicals Limited (National Dairy Development Board)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Panacea Biotec Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Sinovac Biotech Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
List of Figures
Figure 1: Global: Pediatric Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Pediatric Vaccines Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Pediatric Vaccines Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Pediatric Vaccines Market: Breakup by Type (in %), 2021
Figure 5: Global: Pediatric Vaccines Market: Breakup by Technology (in %), 2021
Figure 6: Global: Pediatric Vaccines Market: Breakup by Application (in %), 2021
Figure 7: Global: Pediatric Vaccines Market: Breakup by Region (in %), 2021
Figure 8: Global: Pediatric Vaccines (Multivalent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Pediatric Vaccines (Multivalent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Pediatric Vaccines (Monovalent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Pediatric Vaccines (Monovalent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Pediatric Vaccines (Conjugate) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Pediatric Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Pediatric Vaccines (Live Attenuated) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Pediatric Vaccines (Live Attenuated) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Pediatric Vaccines (Inactivated) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Pediatric Vaccines (Inactivated) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Pediatric Vaccines (Subunit) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Pediatric Vaccines (Subunit) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Pediatric Vaccines (Toxoid) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Pediatric Vaccines (Toxoid) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Pediatric Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Pediatric Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Pediatric Vaccines (Infectious Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Pediatric Vaccines (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Pediatric Vaccines (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Pediatric Vaccines (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Pediatric Vaccines (Allergy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Pediatric Vaccines (Allergy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Pediatric Vaccines (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Pediatric Vaccines (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Pediatric Vaccines Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Pediatric Vaccines Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Pediatric Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Pediatric Vaccines Industry: SWOT Analysis
Figure 82: Global: Pediatric Vaccines Industry: Value Chain Analysis
Figure 83: Global: Pediatric Vaccines Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Pediatric Vaccines Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Pediatric Vaccines Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Pediatric Vaccines Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Pediatric Vaccines Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Pediatric Vaccines Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Pediatric Vaccines Market: Competitive Structure
Table 7: Global: Pediatric Vaccines Market: Key Players